Retraction:

Fucheng Zhou^1*, Yang Li^1*, Zhen Hao¹, Xuanxi Liu¹, Liang Chen¹, Yu Cao¹, Zuobin Liang¹, Fei Yuan¹, Jie Liu¹, Jianjiao Wang¹, Yongri Zheng¹, Deli Dong², Shan Bian³, Baofeng Yang², Chuanlu Jiang¹, and Qingsong Li¹

¹Department of Neurosurgery, The 2nd Affiliated Hospital, Harbin Medical University, Harbin 150086, China
²Harbin Medical University, Harbin 150086, China
³Institute of Molecular Biology, Austrian Academy of Sciences, Vienna, Austria
^*These authors have contributed equally to this work

Published: April 24, 2025

Copyright: © 2025 Zhou et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Oncotarget has completed its investigation of this paper. Several concerns were raised, including internal duplication and overlaps with unrelated papers from different institutions. Specifically, we found that Figure 3G contains overlapping invasion images of U87 and U251 cells transfected with control RNA. Additionally, the Figure 3G invasion image of U87 cells transfected with control RNA overlaps with the invasion image in Figure 3B from an unrelated 2014 paper [1] and duplicates an image found in paper [2], which was submitted and published concurrently. Furthermore, the western blot GAPDH and ROCK1 images in Figure 4F duplicate the GAPDH and RAB22A images published in 2015 in an unrelated and already retracted paper [3]. Finally, Figure 5A contains a GAPDH western blot also found in Figure 4A of an earlier published paper, which has been retracted [4], and in two slightly later published papers, which have also been retracted [5, 6]. We contacted Qingsong Li, the corresponding author, regarding these concerns. Unfortunately, the authors were unable to provide the transwell assay data or western blot images to support the data in the paper. In light of these facts, the Editorial decision was made to retract this paper. The authors did not respond to requests for signed documentation to confirm the retraction.

REFERENCES

1. Chong Y, Zhang J, Guo X, Li G, Zhang S, Li C, Jiao Z, Shao M. MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM. PLoS One. 2014; 9:e114585. https://doi.org/10.1371/journal.pone.0114585. [PubMed]. Retraction in: PLoS One. 2022; 17:e0269900. https://doi.org/10.1371/journal.pone.0269900. [PubMed]

2. Jiang C, Shen F, Du J, Hu Z, Li X, Su J, Wang X, Huang X. MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1. Oncotarget. 2016; 7:56200–208. https://doi.org/10.18632/oncotarget.8987. [PubMed]

3. Yang D, Liu G, Wang K. miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A. PLoS One. 2015; 10:e0132225. https://doi.org/10.1371/journal.pone.0132225. [PubMed]. Retraction in: PLoS One. 2023; 18:e0282979. https://doi.org/10.1371/journal.pone.0282979. [PubMed]

4. Sun L, Bian G, Meng Z, Dang G, Shi D, Mi S. MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression. PLoS One. 2015; 10:e0124428. https://doi.org/10.1371/journal.pone.0124428. [PubMed]. Retraction in: PLoS One. 2022; 17:e0274144. https://doi.org/10.1371/journal.pone.0274144. [PubMed]

5. Geng S, Gu L, Ju F, Zhang H, Wang Y, Tang H, Bi Z, Yang C. MicroRNA-224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1. J Cell Mol Med. 2016; 20:1611–19. https://doi.org/10.1111/jcmm.12852. [PubMed]. Retraction in: J Cell Mol Med. 2019; 23:5832. https://doi.org/10.1111/jcmm.14431. [PubMed]

6. Gao Y, Wang B, Gao S. BRD7 Acts as a Tumor Suppressor Gene in Lung Adenocarcinoma. PLoS One. 2016; 11:e0156701. https://doi.org/10.1371/journal.pone.0156701. [PubMed]. Retraction in: PLoS One. 2023; 18:e0283017. https://doi.org/10.1371/journal.pone.0283017. [PubMed]

Original article: Oncotarget. 2016; 7:36529-36538. DOI: https://doi.org/10.18632/oncotarget.9068.